Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China flag China · Delayed Price · Currency is CNY
16.21
-0.85 (-4.98%)
May 20, 2026, 12:05 PM CST

SHE:002082 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
10,4358,5213,9333,9155,4099,082
Market Cap Growth
202.48%116.64%0.47%-27.62%-40.45%7.23%
Enterprise Value
10,9429,4454,8994,8255,8709,910
Last Close Price
17.0613.936.436.288.5114.27
PE Ratio
--70.9479.5658.0054.55
Forward PE
-6.446.446.446.446.44
PS Ratio
8.877.632.732.543.034.70
PB Ratio
3.873.271.431.421.923.31
P/TBV Ratio
5.474.721.891.852.544.53
P/FCF Ratio
24.4027.11170.18---
P/OCF Ratio
14.3114.1132.72--411.24
EV/Sales Ratio
9.308.453.393.133.295.13
EV/EBITDA Ratio
73.43170.7928.7529.4217.4032.48
EV/EBIT Ratio
--65.5268.7425.2447.04
EV/FCF Ratio
25.5830.05211.95---
Debt / Equity Ratio
0.370.380.370.350.310.31
Debt / EBITDA Ratio
6.6915.535.935.842.552.76
Debt / FCF Ratio
2.333.1344.49---
Net Debt / Equity Ratio
0.160.170.310.270.14-0.02
Net Debt / EBITDA Ratio
2.997.935.044.571.18-0.23
Net Debt / FCF Ratio
0.991.4037.14-3.72-0.970.26
Asset Turnover
0.270.260.340.360.420.39
Inventory Turnover
3.193.263.613.413.131.80
Quick Ratio
0.950.910.931.091.571.63
Current Ratio
1.231.231.371.451.941.92
Return on Equity (ROE)
-3.02%-6.41%1.64%0.94%2.65%5.75%
Return on Assets (ROA)
0.39%-0.78%1.08%1.03%3.38%2.63%
Return on Invested Capital (ROIC)
0.89%-1.64%1.61%1.84%5.81%2.75%
Return on Capital Employed (ROCE)
0.90%-1.80%2.50%2.40%7.50%6.80%
Earnings Yield
-0.76%-1.96%1.41%1.26%1.72%1.83%
FCF Yield
4.10%3.69%0.59%-5.15%-7.52%-2.90%
Dividend Yield
---1.27%1.41%-
Payout Ratio
--163.85%247.98%47.08%115.10%
Buyback Yield / Dilution
-0.69%-0.55%-0.15%1.06%-0.82%-1.73%
Total Shareholder Return
-0.69%-0.55%-0.15%2.34%0.59%-1.73%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.